Richard A. Knight

27.7k total citations · 1 hit paper
201 papers, 11.9k citations indexed

About

Richard A. Knight is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Richard A. Knight has authored 201 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 57 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Richard A. Knight's work include Cancer-related Molecular Pathways (45 papers), Cell death mechanisms and regulation (22 papers) and Stress Responses and Cortisol (21 papers). Richard A. Knight is often cited by papers focused on Cancer-related Molecular Pathways (45 papers), Cell death mechanisms and regulation (22 papers) and Stress Responses and Cortisol (21 papers). Richard A. Knight collaborates with scholars based in United Kingdom, Italy and United States. Richard A. Knight's co-authors include Gerry Melino, Anastasis Stephanou, David S. Latchman, Tiziano M. Scarabelli, Massimiliano Agostini, M.E. Hodson, Eleonora Candi, Paul A. Townsend, Alessandro Terrinoni and Ivano Amelio and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard A. Knight

198 papers receiving 11.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

2005 598 citations Richard A. Knight, Gerry Melino et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard A. Knight United Kingdom	63	6.6k	3.1k	2.3k	1.1k	1.1k	201	11.9k
Xu Cao United States	63	7.5k 1.1×	2.5k 0.8×	1.6k 0.7×	1.0k 1.0×	672 0.6×	192	13.6k
Jianhua Zhang China	59	6.7k 1.0×	2.0k 0.6×	2.7k 1.2×	1.4k 1.3×	1.1k 1.0×	396	13.0k
Daniel R. Marshak United States	33	9.0k 1.4×	2.5k 0.8×	1.8k 0.8×	1.2k 1.1×	1.1k 1.0×	64	21.8k
Jie Li China	56	6.6k 1.0×	2.0k 0.6×	2.7k 1.2×	1.3k 1.2×	1.0k 1.0×	587	14.6k
Steven R. Goldring United States	66	7.6k 1.2×	3.4k 1.1×	2.2k 0.9×	1.7k 1.6×	660 0.6×	192	19.9k
Jiake Xu Australia	69	8.3k 1.3×	3.3k 1.1×	2.4k 1.0×	1.9k 1.8×	1.0k 1.0×	412	17.4k
Yukio Kato Japan	65	6.6k 1.0×	2.4k 0.8×	2.0k 0.9×	946 0.9×	552 0.5×	414	15.5k
Takashi Nakamura Japan	59	5.3k 0.8×	2.1k 0.7×	1.3k 0.6×	750 0.7×	678 0.6×	334	12.9k
Boon‐Huat Bay Singapore	61	4.3k 0.6×	1.4k 0.5×	1.6k 0.7×	790 0.7×	1.3k 1.2×	306	12.6k
Tong‐Chuan He United States	57	11.3k 1.7×	3.5k 1.2×	2.3k 1.0×	1.3k 1.2×	1.3k 1.2×	268	17.7k

Countries citing papers authored by Richard A. Knight

Since Specialization

Citations

This map shows the geographic impact of Richard A. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Knight more than expected).

Fields of papers citing papers by Richard A. Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Knight. The network helps show where Richard A. Knight may publish in the future.

Co-authorship network of co-authors of Richard A. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Knight. A scholar is included among the top collaborators of Richard A. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Knight. Richard A. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butera, Alessio, Massimiliano Agostini, Matteo Cassandri, et al.. (2023). ZFP750 affects the cutaneous barrier through regulating lipid metabolism. Science Advances. 9(17). eadg5423–eadg5423. 14 indexed citations

Cassandri, Matteo, Alessio Butera, Ivano Amelio, et al.. (2020). ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes. Oncogene. 39(22). 4331–4343. 29 indexed citations

Amelio, Ivano, Emanuele Panatta, Maria Victoria Niklison-Chirou, et al.. (2020). The C terminus of p73 is essential for hippocampal development. Proceedings of the National Academy of Sciences. 117(27). 15694–15701. 21 indexed citations

Panatta, Emanuele, Nobuhiro Morone, Luca Scorrano, et al.. (2020). P73 C-terminus is dispensable for multiciliogenesis. Cell Cycle. 19(14). 1833–1845. 10 indexed citations

Marini, Alberto, Barak Rotblat, Thomas Sbarrato, et al.. (2018). TAp73 contributes to the oxidative stress response by regulating protein synthesis. Proceedings of the National Academy of Sciences. 115(24). 6219–6224. 27 indexed citations

Petrova, Varvara, Mara Mancini, Nicola Di Daniele, et al.. (2017). TAp73 upregulates IL-1β in cancer cells: Potential biomarker in lung and breast cancer?. Biochemical and Biophysical Research Communications. 482(3). 498–505. 23 indexed citations

Amelio, Ivano, Nick A. Barlev, Richard A. Knight, et al.. (2015). Perspective on Multi-Target Antiplatelet Therapies: High Content Phenotypic Screening as an Unbiased Source of Novel Polypharmacological Strategies. Mini-Reviews in Medicinal Chemistry. 15(8). 622–629. 3 indexed citations

Krestyaninova, Maria, et al.. (2013). PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene. 33(13). 1621–1628. 50 indexed citations

Terrinoni, Alessandro, Valeria Serra, Ernesto Bruno, et al.. (2013). Role of p63 and the Notch pathway in cochlea development and sensorineural deafness. Proceedings of the National Academy of Sciences. 110(18). 7300–7305. 37 indexed citations

10.

Velletri, Tania, Francesco Romeo, Paola Tucci, et al.. (2013). GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle. 12(22). 3564–3573. 76 indexed citations

11.

Amelio, Ivano, Gerry Melino, & Richard A. Knight. (2011). Cell death pathology: Cross-talk with autophagy and its clinical implications. Biochemical and Biophysical Research Communications. 414(2). 277–281. 66 indexed citations

12.

McCormick, James A., et al.. (2011). STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. Journal of Cellular and Molecular Medicine. 16(2). 386–393. 73 indexed citations

13.

Hudson, Christopher, Emre Sayan, Gerry Melino, et al.. (2008). Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription. Cell Death and Differentiation. 15(8). 1266–1278. 10 indexed citations

14.

Barcaroli, Daniela, Lucilla Bongiorno‐Borbone, Alessandro Terrinoni, et al.. (2006). FLASH is required for histone transcription and S-phase progression. Proceedings of the National Academy of Sciences. 103(40). 14808–14812. 104 indexed citations

15.

Barcaroli, Daniela, David Dinsdale, Michael H. Neale, et al.. (2006). FLASH is an essential component of Cajal bodies. Proceedings of the National Academy of Sciences. 103(40). 14802–14807. 50 indexed citations

16.

Bloor, Claire, et al.. (2001). Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 164(2). 265–272. 35 indexed citations

17.

Brar, Bhawanjit K., Anastasis Stephanou, Giorgia Santilli, et al.. (2000). Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway. Journal of Biological Chemistry. 275(12). 8508–8514. 212 indexed citations

18.

Brar, Bhawanjit K., Anastasis Stephanou, Kevin M. Lawrence, et al.. (1999). CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Molecular and Cellular Endocrinology. 158(1-2). 55–63. 99 indexed citations

19.

Knight, Richard A., et al.. (1993). The HVOF process - the hottest topic in the thermal spray industry. Welding Journal. 72(7). 25–30. 17 indexed citations

20.

Stephanou, Anastasis, Stafford L. Lightman, Richard A. Knight, & Gerry Melino. (1990). Expression of proopiomelanocortin and corticotrophin releasing factor mRNA in human lymphocytes and neuroblastomas. 2. 261–267. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact